The Potential of NLRP3 Inflammasome as a Therapeutic Target in Neurological Diseases

[1]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  Hongbin He,et al.  Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis , 2022, Frontiers in Cell and Developmental Biology.

[3]  Xiankun Tu,et al.  Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage , 2022, Chinese Journal of Integrative Medicine.

[4]  zhao yang,et al.  VSIG4 Attenuates NLRP3 and Ameliorates Neuroinflammation via JAK2-STAT3-A20 Pathway after Intracerebral Hemorrhage in Mice , 2022, Neurotoxicity Research.

[5]  Baoman Li,et al.  The neuroprotective mechanism of lithium after ischaemic stroke , 2021, Communications Biology.

[6]  Canwen Liu,et al.  Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2 , 2021, Oxidative medicine and cellular longevity.

[7]  G. Stoll,et al.  NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood–brain barrier integrity in murine stroke , 2021, Cell Death & Disease.

[8]  V. Naidu,et al.  Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease. , 2021, ACS chemical neuroscience.

[9]  Haitao Wang,et al.  Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment , 2021, Frontiers in Immunology.

[10]  Hao Wu,et al.  NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation , 2021, Cell.

[11]  Yan Peng,et al.  NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression , 2021, Frontiers in Aging Neuroscience.

[12]  J. Ornato,et al.  Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  Shu Yu,et al.  Anti-inflammatory Activity of a Polypeptide Fraction From Achyranthes bidentate in Amyloid β Oligomers Induced Model of Alzheimer’s Disease , 2021, Frontiers in Pharmacology.

[14]  X. Xiong,et al.  Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition , 2021, Frontiers in Immunology.

[15]  B. Hoh,et al.  NLRP3 inhibition attenuates early brain injury and delayed cerebral vasospasm after subarachnoid hemorrhage , 2021, Journal of Neuroinflammation.

[16]  T. Pufe,et al.  Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells , 2021, Cells.

[17]  Jing Zhao,et al.  FUNDC1 inhibits NLRP3-mediated inflammation after intracerebral hemorrhage by promoting mitophagy in mice , 2021, Neuroscience Letters.

[18]  N. Toschi,et al.  Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence , 2021, Ageing Research Reviews.

[19]  Yue Liu,et al.  Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis , 2021, Laboratory Investigation.

[20]  R. Leite,et al.  NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-β in sclerotic hippocampi , 2020, Brain Research.

[21]  B. Law,et al.  Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases , 2020, Ageing Research Reviews.

[22]  W. Mi,et al.  Repeated propofol exposure-induced neuronal damage and cognitive impairment in aged rats by activation of NF-κB pathway and NLRP3 inflammasome , 2020, Neuroscience Letters.

[23]  John H. Zhang,et al.  INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats , 2020, Brain, Behavior, and Immunity.

[24]  S. Nasoohi,et al.  Verapamil as an Adjunct Therapy to Reduce tPA Toxicity in Hyperglycemic Stroke: Implication of TXNIP/NLRP3 Inflammasome , 2020, Molecular Neurobiology.

[25]  QuanQiu Wang,et al.  Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease , 2020, Science Advances.

[26]  P. Greengard,et al.  Innate immunity protein IFITM3 modulates γ-secretase in Alzheimer disease , 2020, Nature.

[27]  Xuan Li,et al.  MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation , 2020, Journal of neuroinflammation.

[28]  Xiaolei Shi,et al.  TREM-1 Exacerbates Neuroinflammatory Injury via NLRP3 Inflammasome-Mediated Pyroptosis in Experimental Subarachnoid Hemorrhage , 2020, Translational Stroke Research.

[29]  B. Law,et al.  Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[30]  E. Yoshihara.  TXNIP/TBP-2: A Master Regulator for Glucose Homeostasis , 2020, Antioxidants.

[31]  R. Zhou,et al.  Golgi Apparatus: An Emerging Platform for Innate Immunity. , 2020, Trends in cell biology.

[32]  Lei He,et al.  Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity. , 2020, Molecular immunology.

[33]  Xiangmei Zhou,et al.  The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation , 2020, Cells.

[34]  K. Xie,et al.  Hydrogen attenuates sepsis-associated encephalopathy by NRF2 mediated NLRP3 pathway inactivation , 2020, Inflammation Research.

[35]  Q. Guan,et al.  Mechanism of microRNA‐22 in regulating neuroinflammation in Alzheimer’s disease , 2020, Brain and behavior.

[36]  F. Matesanz,et al.  NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. , 2020, Brain : a journal of neurology.

[37]  S. Shultz,et al.  The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target , 2020, Journal of Neuroinflammation.

[38]  V. Gradinaru,et al.  LRP1 is a master regulator of tau uptake and spread , 2020, Nature.

[39]  Q. Ao,et al.  MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome activation. , 2020, International immunopharmacology.

[40]  Xiao-Min Wang,et al.  Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease , 2020, Journal of Neuroinflammation.

[41]  Wanqun Xie,et al.  Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice. , 2020, International immunopharmacology.

[42]  F. Gao,et al.  α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome , 2019, Experimental and therapeutic medicine.

[43]  M. Heneka,et al.  Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia , 2019, Journal of neurochemistry.

[44]  L. Buée,et al.  NLRP3 inflammasome activation drives tau pathology , 2019, Nature.

[45]  G. Donnan,et al.  Ischaemic stroke , 2019, Nature Reviews Disease Primers.

[46]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[47]  H. Steiger,et al.  Experimental Aneurysmal Subarachnoid Hemorrhage: Tiding Over , 2019, Translational Stroke Research.

[48]  M. Heneka,et al.  Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome , 2019, The EMBO journal.

[49]  Hidenori Suzuki,et al.  Inflammation: a Good Research Target to Improve Outcomes of Poor-Grade Subarachnoid Hemorrhage , 2019, Translational Stroke Research.

[50]  Shizhong Zhang,et al.  Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation , 2019, EBioMedicine.

[51]  Yang Ruan,et al.  Kainic acid Induces production and aggregation of amyloid β-protein and memory deficits by activating inflammasomes in NLRP3- and NF-κB-stimulated pathways , 2019, Aging.

[52]  Zhi-Jian You,et al.  NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes , 2019, Journal of Neuroinflammation.

[53]  C. Day,et al.  MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition , 2019, Nature Chemical Biology.

[54]  C. Fekete,et al.  Chronic Amyloid β Oligomer Infusion Evokes Sustained Inflammation and Microglial Changes in the Rat Hippocampus via NLRP3 , 2019, Neuroscience.

[55]  T. Dawson,et al.  Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia , 2019, The Journal of experimental medicine.

[56]  Ye Xu,et al.  Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis. , 2019, Antioxidants & redox signaling.

[57]  J. Filosa,et al.  NLRP3 inflammasome inhibition with MCC950 improves diabetes‐mediated cognitive impairment and vasoneuronal remodeling after ischemia , 2019, Pharmacological research.

[58]  Sheng Chen,et al.  MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats , 2019, Brain Research Bulletin.

[59]  I. Dewachter,et al.  Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo , 2019, Acta Neuropathologica.

[60]  Z. Gu,et al.  NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis. , 2019, Current neurovascular research.

[61]  Zhengzheng Liao,et al.  Intracerebroventricular injection of resveratrol ameliorated Aβ-induced learning and cognitive decline in mice , 2018, Metabolic Brain Disease.

[62]  Zhijian J. Chen,et al.  PtdIns4P on Dispersed Trans-Golgi Network Mediates NLRP3 Inflammasome Activation , 2018, Nature.

[63]  Xiao-Xin Yan,et al.  Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice , 2018, Front. Mol. Neurosci..

[64]  Yingliang Wu,et al.  Cholesterol Homeostatic Regulator SCAP‐SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages , 2018, Immunity.

[65]  K. Schroder,et al.  Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice , 2018, Science Translational Medicine.

[66]  M. Ji,et al.  NLRP3/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy , 2018, Inflammation.

[67]  X. Montalban,et al.  NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients , 2018, Multiple sclerosis.

[68]  Guy C. Brown,et al.  Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease , 2018, The FEBS journal.

[69]  Z. Salehi,et al.  Association of nod‐like receptor protein‐3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing–remitting multiple sclerosis , 2018, International journal of immunogenetics.

[70]  C. Lecrux,et al.  Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model , 2018, Nature Communications.

[71]  G. López-Castejón,et al.  Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming , 2018, Proceedings of the National Academy of Sciences.

[72]  Fei Li,et al.  Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury , 2018, Neurobiology of Disease.

[73]  Ying Peng,et al.  Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury , 2018, Journal of Neuroinflammation.

[74]  Qianchao He,et al.  Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model , 2018, Current neurovascular research.

[75]  A. Malik,et al.  The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome‐Induced Inflammation , 2018, Immunity.

[76]  M. Rowan,et al.  NLRP3-dependent synaptic plasticity deficit in an Alzheimer's disease amyloidosis model in vivo , 2018, Neurobiology of Disease.

[77]  S. Nasoohi,et al.  MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury. , 2018, Journal of neurotrauma.

[78]  Inhwa Hwang,et al.  MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration , 2018, Cell Death & Differentiation.

[79]  S. Nasoohi,et al.  Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke , 2018, Scientific Reports.

[80]  Wei Liu,et al.  Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage , 2018, Experimental and therapeutic medicine.

[81]  Guibo Sun,et al.  Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice , 2018, Molecules.

[82]  T. Arumugam,et al.  Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke , 2017, Molecular Neurobiology.

[83]  M. Cooper,et al.  Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain , 2017, Inflammopharmacology.

[84]  M. Heneka,et al.  Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease , 2017, Nature.

[85]  Qingsong Liu,et al.  Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders , 2017, The Journal of experimental medicine.

[86]  C. Hang,et al.  Resveratrol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage via Inhibition of NLRP3 Inflammasome Activation , 2017, Front. Neurosci..

[87]  Souvarish Sarkar,et al.  Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease , 2017, npj Parkinson's Disease.

[88]  Jiahuai Han,et al.  Protein kinase D at the Golgi controls NLRP3 inflammasome activation , 2017, The Journal of experimental medicine.

[89]  L. An,et al.  Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling–Induced Nontranscriptional Priming of the NLRP3 Inflammasome , 2017, The Journal of Immunology.

[90]  Miao-jing Wu,et al.  Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[91]  Yanghao Hou,et al.  Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1‐dependent autophagy induction , 2017, International immunopharmacology.

[92]  Beth Stevens,et al.  Microglia emerge as central players in brain disease , 2017, Nature Medicine.

[93]  A. Bitto,et al.  Lack of the Nlrp3 Inflammasome Improves Mice Recovery Following Traumatic Brain Injury , 2017, Front. Pharmacol..

[94]  Jingde Wu,et al.  Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis. , 2017, ACS chemical neuroscience.

[95]  Lei Bao,et al.  Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse , 2017, Experimental Neurology.

[96]  Guangyu Ying,et al.  Melatonin-mediated mitophagy protects against early brain injury after subarachnoid hemorrhage through inhibition of NLRP3 inflammasome activation , 2017, Scientific Reports.

[97]  K. Schroder,et al.  NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. , 2017, Journal of hepatology.

[98]  J. Sáez,et al.  High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring , 2017, Developmental neurobiology.

[99]  M. Prinz,et al.  Ontogeny and homeostasis of CNS myeloid cells , 2017, Nature Immunology.

[100]  S. Allan,et al.  A brain in flame; do inflammasomes and pyroptosis influence stroke pathology? , 2017, Brain pathology.

[101]  M. Lynch,et al.  Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice , 2017, Brain, Behavior, and Immunity.

[102]  Qingmei Yang,et al.  The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats , 2017, Neurochemical Research.

[103]  A. Liston,et al.  Homeostasis-altering molecular processes as mechanisms of inflammasome activation , 2017, Nature Reviews Immunology.

[104]  Yihui Ma,et al.  Pterostilbene Attenuates Early Brain Injury Following Subarachnoid Hemorrhage via Inhibition of the NLRP3 Inflammasome and Nox2-Related Oxidative Stress , 2016, Molecular Neurobiology.

[105]  Ming Lu,et al.  Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson’s Disease , 2017, Molecular Neurobiology.

[106]  E. Latz,et al.  Assembly and regulation of ASC specks , 2017, Cellular and Molecular Life Sciences.

[107]  Song Jiao,et al.  NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH , 2017, Journal of Molecular Neuroscience.

[108]  D. Brough,et al.  Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models , 2016, Nature Communications.

[109]  G. Dubyak,et al.  NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx. , 2016, American journal of physiology. Cell physiology.

[110]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[111]  James R. Springstead,et al.  An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells , 2016, Science.

[112]  A. Bitto,et al.  ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury , 2016, Oxidative medicine and cellular longevity.

[113]  Sally Freeman,et al.  Inhibiting the Inflammasome: A Chemical Perspective. , 2016, Journal of medicinal chemistry.

[114]  E. Calabrese,et al.  The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease , 2016, Molecular Neurodegeneration.

[115]  G. Núñez,et al.  Nek7 is an essential mediator of NLRP3 activation downstream of potassium efflux , 2016, Nature.

[116]  B. Beutler,et al.  NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component , 2015, Nature Immunology.

[117]  D. Troost,et al.  NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients , 2015, Glia.

[118]  Allison J. Greaney,et al.  Bacterial Exotoxins and the Inflammasome , 2015, Front. Immunol..

[119]  Yizhao Chen,et al.  P2X7R blockade prevents NLRP3 inflammasome activation and brain injury in a rat model of intracerebral hemorrhage: involvement of peroxynitrite , 2015, Journal of Neuroinflammation.

[120]  Bangqing Yuan,et al.  Recombinant adenovirus encoding NLRP3 RNAi attenuate inflammation and brain injury after intracerebral hemorrhage , 2015, Journal of Neuroimmunology.

[121]  K. Schroder,et al.  NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.

[122]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[123]  K. Hua,et al.  Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy , 2015, Journal of cellular physiology.

[124]  D. Klenerman,et al.  Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons , 2015, Cell Death and Disease.

[125]  A. Tardivel,et al.  NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes , 2015, PloS one.

[126]  Bangqing Yuan,et al.  MicroRNA-223 regulates inflammation and brain injury via feedback to NLRP3 inflammasome after intracerebral hemorrhage. , 2015, Molecular immunology.

[127]  X. Montalban,et al.  NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis. , 2015, Brain : a journal of neurology.

[128]  K. Schroder,et al.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.

[129]  P. A. Crawford,et al.  Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.

[130]  Jin-Tai Yu,et al.  Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus , 2014, Journal of Neuroinflammation.

[131]  P. Li,et al.  Inflammatory caspases are innate immune receptors for intracellular LPS , 2014, Nature.

[132]  M. Mattson,et al.  Intermittent fasting attenuates inflammasome activity in ischemic stroke , 2014, Experimental Neurology.

[133]  Caiping Wang,et al.  Mulberroside a protects against ischemic impairment in primary culture of rat cortical neurons after oxygen–glucose deprivation followed by reperfusion , 2014, Journal of neuroscience research.

[134]  Katherine A. Fitzgerald,et al.  Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes , 2014, Cell.

[135]  John H. Zhang,et al.  NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage , 2014, Annals of neurology.

[136]  Ziying Wang,et al.  NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[137]  John H. Zhang,et al.  P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH , 2013, Neurobiology of Disease.

[138]  T. Arumugam,et al.  Pathogenesis of acute stroke and the role of inflammasomes , 2013, Ageing Research Reviews.

[139]  M. Mattson,et al.  Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke , 2013, Cell Death and Disease.

[140]  F. Sutterwala,et al.  Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. , 2013, Immunity.

[141]  G. Núñez,et al.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.

[142]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[143]  G. López-Castejón,et al.  NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury , 2012, Front. Immun..

[144]  Jiujiu Yu,et al.  Critical role for calcium mobilization in activation of the NLRP3 inflammasome , 2012, Proceedings of the National Academy of Sciences.

[145]  P. Vandenabeele,et al.  Interferon-β Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome , 2012, Science Signaling.

[146]  N. Rothwell,et al.  Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target , 2011, Cerebrovascular Diseases.

[147]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[148]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[149]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[150]  B. Tranmer,et al.  Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein , 2011, Translational Stroke Research.

[151]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[152]  G. Núñez,et al.  Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.

[153]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[154]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[155]  J. Tschopp,et al.  Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica , 2008, Science.

[156]  E. Alnemri,et al.  The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation , 2007, Cell Death and Differentiation.

[157]  Z. Ye,et al.  Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling , 2007, Proceedings of the National Academy of Sciences.

[158]  Qing Wang,et al.  The inflammatory response in stroke , 2007, Journal of Neuroimmunology.

[159]  G. Donnan,et al.  1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.

[160]  E. Remmers,et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.

[161]  G. Hitman,et al.  Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. , 2002, Arthritis and rheumatism.

[162]  R. Kolodner,et al.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.